PCI Synthesis, Inc., a pharmaceutical manufacturer of new chemical entities, generic active pharmaceutical ingredients (APIs), and other chemical products, has appointed Scott VanderWel as Business Development Manager.

Joining with two decades of industry experience, his job responsibilities will focus around leading sales and marketing efforts for the West Coast. The San Diego office that VanderWel will be based out of is the company’s first location outside of Massachusetts.

“The addition of Scott to our team helps us to better support West Coast-based biotech, an important area of growth for us,” said Ed Price, president of PCI Synthesis. “Scott has been successful in business development over the last decade because he spent the prior decade working in the lab. Having been on the sponsor side, with a clear understanding of what works, Scott is able to use that experience to help us better serve our West Coast partners.”

Prior to joining PCI Synthesis, VanderWel served as Director of Business Development at Albany Molecular Research and BPS Bioscience.